Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -46.45% is 12% below its 5-year average of -41.46%, around the middle of its 5-year range (-63.84%–-23.85%).
4.38% above its 12-month average of -48.58%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -10.33%.
RETURN ON ASSETS (ROA)
-46.45%
RETURN ON ASSETS (ROA) AVG TTM
-48.58%
RETURN ON ASSETS (ROA) AVG 3Y
-49.83%
RETURN ON ASSETS (ROA) AVG 5Y
-41.46%
RETURN ON ASSETS (ROA) AVG 10Y
-37.03%
RETURN ON ASSETS (ROA) AVG 15Y
-41.82%
RETURN ON ASSETS (ROA) AVG 20Y
-42.29%
CURRENT VS TTM AVG
+4.38%
CURRENT VS 3Y AVG
+6.79%
CURRENT VS 5Y AVG
-12.03%
CURRENT VS 10Y AVG
-25.44%
CURRENT VS 15Y AVG
-11.08%
CURRENT VS 20Y AVG
-9.83%
SECTOR MEDIAN · HEALTHCARE
-27.35%
median of 507 covered companies
CURRENT VS SECTOR MEDIAN
-69.84%
vs the sector median at left
Cytokinetics, Incorporated
Market Cap
$7.73B
Return on Assets (ROA)
-46.45%
TTM Avg
-48.58%
3Y Avg
-49.83%
5Y Avg
-41.46%
Market Cap
$7.65B
Return on Assets (ROA)
7.23%
TTM Avg
4.54%
3Y Avg
2.50%
5Y Avg
1.48%
Market Cap
$7.66B
Return on Assets (ROA)
13.18%
TTM Avg
-36.35%
3Y Avg
-30.02%
5Y Avg
-30.02%
Market Cap
$7.34B
Return on Assets (ROA)
-18.86%
TTM Avg
-12.96%
3Y Avg
-12.20%
5Y Avg
-11.41%
Market Cap
$7.15B
Return on Assets (ROA)
1.51%
TTM Avg
13.71%
3Y Avg
9.00%
5Y Avg
4.65%
Market Cap
$8.43B
Return on Assets (ROA)
4.91%
TTM Avg
-3.24%
3Y Avg
-6.85%
5Y Avg
-10.42%
Market Cap
$6.96B
Return on Assets (ROA)
-63.13%
TTM Avg
-53.05%
3Y Avg
-49.25%
5Y Avg
-42.24%
Market Cap
$8.68B
Return on Assets (ROA)
8.55%
TTM Avg
-64.90%
3Y Avg
-64.30%
5Y Avg
-51.23%
Market Cap
$6.71B
Return on Assets (ROA)
17.41%
TTM Avg
17.14%
3Y Avg
16.98%
5Y Avg
18.36%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytokinetics, Incorporated (CYTK) | $7.73B | -46.45% | -48.58% | -49.83% | -41.46% |
| HealthEquity, Inc. (HQY)vs › | $7.65B | 7.23% | 4.54% | 2.50% | 1.48% |
| Hinge Health, Inc. (HNGE)vs › | $7.66B | 13.18% | -36.35% | -30.02% | -30.02% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.34B | -18.86% | -12.96% | -12.20% | -11.41% |
| Alkermes plc (ALKS)vs › | $7.15B | 1.51% | 13.71% | 9.00% | 4.65% |
| Oscar Health, Inc. (OSCR)vs › | $8.43B | 4.91% | -3.24% | -6.85% | -10.42% |
| Immunovant, Inc. (IMVT)vs › | $6.96B | -63.13% | -53.05% | -49.25% | -42.24% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.68B | 8.55% | -64.90% | -64.30% | -51.23% |
| Chemed Corporation (CHE)vs › | $6.71B | 17.41% | 17.14% | 16.98% | 18.36% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.69B | -3.91% | 11.88% | 0.12% | -6.73% |
ROA
-46.5%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -55.10% |
| 2024-12-31 | -42.06% |
| 2023-12-31 | -63.84% |
| 2022-12-31 | -38.33% |
| 2021-12-31 | -25.59% |
| 2020-12-31 | -23.85% |
| 2019-12-31 | -41.99% |
| 2018-12-31 | -50.33% |
| 2017-12-31 | -43.35% |
| 2016-12-31 | 9.67% |
| 2015-12-31 | -32.54% |
| 2014-12-31 | -11.01% |
| 2013-12-31 | -40.53% |
| 2012-12-31 | -53.74% |
| 2011-12-31 | -90.69% |
| 2010-12-31 | -63.19% |
| 2009-12-31 | 20.02% |
| 2008-12-31 | -64.46% |
| 2007-12-31 | -31.47% |
| 2006-12-31 | -33.69% |
| 2005-12-31 | -46.20% |
| 2004-12-31 | -29.04% |
| 2003-12-31 | -51.99% |
| 2002-12-31 | -41.09% |
| 2001-12-31 | -20.09% |
| 2000-12-31 | -21.43% |
